Target intelligence / Profile preview

Novel transcript, antisense to transmembrane protein 102 (ENSG00000262624)

Target
ENSG00000262624
Molecular classification
Antisense transcript, Non-coding RNA
01

Overview

ENSG00000262624 refers to a novel transcript, antisense to the TMEM102 gene, annotated by Ensembl as a putative non-coding RNA. There is no protein product associated with this transcript, and it is not recognized as a therapeutic target or biomarker. While its genomic proximity may allow for potential regulatory interactions with TMEM102 (transmembrane protein 102), no published evidence currently demonstrates such function or clinical relevance. No drugs, disease roles, or safety concerns have been linked to this transcript, indicating it is not an established molecular target in any context. The gene TMEM102 (Ensembl ID: ENSG00000181284) is a protein-coding gene with roles in apoptotic signaling and cell adhesion—these functions only apply to the sense TMEM102 gene and protein, not this antisense transcript. Transcript ENSG00000262624 does not correspond to TMEM102 itself and should not be mistaken for the protein target. If further context emerges about ENSG00000262624 itself—such as experimental validation, disease association, or functional data—its classification may change. Currently, it is not a therapeutically relevant entity.

Other names
novel transcript, antisense to TMEM102ENSG00000262624
02

Biological functions

None experimentally validated
03

Disease associations

None recognized

Beyond the preview

Go deeper on Novel transcript, antisense to transmembrane protein 102 (ENSG00000262624).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to transmembrane protein 102 (ENSG00000262624).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call